ELI LILLY & Co — LLY

CIK

0000059478

Tickers

LLY

Exchange

NYSE

SIC

2834 Pharmaceutical Preparations

Status

ok

{"freshness":{"dto_schema_version":"meridian-agent-site/v1","status":"ok","status_reason":"ok","tearsheet_asof":"2026-07-16","tearsheet_schema_version":"financial-tearsheets/v1"},"identity":{"aliases":["LLY"],"canonical_ticker":"LLY","cik":"0000059478","exchange":"NYSE","industry_key":"healthcare","name":"ELI LILLY & Co","sic":"2834","sic_description":"Pharmaceutical Preparations"},"shares":{"as_of":"2026-07-08","float_shares":842033032,"free_float_factor":0.894123,"total_shares":941741406}}

fundamentals[110]{fiscal_year,end,metric,value,unit,currency,filing_date,form,accession,concept}:
  2025,2025-12-31,revenue,65179000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:Revenues"
  2025,2025-12-31,cost_of_revenue,11052000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:CostOfGoodsAndServicesSold"
  2025,2025-12-31,selling_general_and_administrative,11094000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:SellingGeneralAndAdministrativeExpense"
  2025,2025-12-31,research_and_development,13337000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"
  2025,2025-12-31,interest_expense,895000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:InterestExpenseNonoperating"
  2025,2025-12-31,pretax_income,25731000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
  2025,2025-12-31,income_tax_expense,5091000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:IncomeTaxExpenseBenefit"
  2025,2025-12-31,net_income,20640000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:NetIncomeLoss"
  2025,2025-12-31,cash_and_equivalents,7268000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:CashAndCashEquivalentsAtCarryingValue"
  2025,2025-12-31,current_assets,55629000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:AssetsCurrent"
  2025,2025-12-31,total_assets,112476000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:Assets"
  2025,2025-12-31,current_liabilities,35228000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:LiabilitiesCurrent"
  2025,2025-12-31,total_debt,42503000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:DebtLongtermAndShorttermCombinedAmount"
  2025,2025-12-31,stockholders_equity,26535000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:StockholdersEquity"
  2025,2025-12-31,operating_cash_flow,16813000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:NetCashProvidedByUsedInOperatingActivities"
  2025,2025-12-31,depreciation_and_amortization,1997000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:DepreciationDepletionAndAmortization"
  2025,2025-12-31,stock_based_compensation,626000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:ShareBasedCompensation"
  2025,2025-12-31,capex,7841000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment"
  2025,2025-12-31,free_cash_flow,8972000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"derived:operating_cash_flow-minus-capex"
  2025,2025-12-31,dividends_paid,5384000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:PaymentsOfDividends"
  2025,2025-12-31,share_repurchases,4108000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:PaymentsForRepurchaseOfCommonStock"
  2025,2025-12-31,impairments,0.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:GoodwillImpairmentLoss"
  2025,2024-12-31,revenue,45043000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:Revenues"
  2025,2024-12-31,cost_of_revenue,8418000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:CostOfGoodsAndServicesSold"
  2025,2024-12-31,selling_general_and_administrative,8594000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:SellingGeneralAndAdministrativeExpense"
  2025,2024-12-31,research_and_development,10991000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"
  2025,2024-12-31,interest_expense,781000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:InterestExpenseNonoperating"
  2025,2024-12-31,pretax_income,12680000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
  2025,2024-12-31,income_tax_expense,2090000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:IncomeTaxExpenseBenefit"
  2025,2024-12-31,net_income,10590000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:NetIncomeLoss"
  2025,2024-12-31,cash_and_equivalents,3268000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:CashAndCashEquivalentsAtCarryingValue"
  2025,2024-12-31,current_assets,32740000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:AssetsCurrent"
  2025,2024-12-31,total_assets,78715000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:Assets"
  2025,2024-12-31,current_liabilities,28376000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:LiabilitiesCurrent"
  2025,2024-12-31,total_debt,33644000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:DebtLongtermAndShorttermCombinedAmount"
  2025,2024-12-31,stockholders_equity,14272000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:StockholdersEquity"
  2025,2024-12-31,operating_cash_flow,8818000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:NetCashProvidedByUsedInOperatingActivities"
  2025,2024-12-31,depreciation_and_amortization,1767000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:DepreciationDepletionAndAmortization"
  2025,2024-12-31,stock_based_compensation,646000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:ShareBasedCompensation"
  2025,2024-12-31,capex,5058000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment"
  2025,2024-12-31,free_cash_flow,3760000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"derived:operating_cash_flow-minus-capex"
  2025,2024-12-31,dividends_paid,4680000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:PaymentsOfDividends"
  2025,2024-12-31,share_repurchases,2500000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:PaymentsForRepurchaseOfCommonStock"
  2025,2024-12-31,impairments,0.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:GoodwillImpairmentLoss"
  2025,2023-12-31,revenue,34124000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:Revenues"
  2025,2023-12-31,cost_of_revenue,7082000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:CostOfGoodsAndServicesSold"
  2025,2023-12-31,selling_general_and_administrative,7404000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:SellingGeneralAndAdministrativeExpense"
  2025,2023-12-31,research_and_development,9313000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"
  2025,2023-12-31,interest_expense,485900000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:InterestExpense"
  2025,2023-12-31,pretax_income,6554000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
  2025,2023-12-31,income_tax_expense,1314000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:IncomeTaxExpenseBenefit"
  2025,2023-12-31,net_income,5240000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:NetIncomeLoss"
  2025,2023-12-31,cash_and_equivalents,2818600000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:CashAndCashEquivalentsAtCarryingValue"
  2025,2023-12-31,current_assets,25727000000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:AssetsCurrent"
  2025,2023-12-31,total_assets,64006300000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:Assets"
  2025,2023-12-31,current_liabilities,27293200000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:LiabilitiesCurrent"
  2025,2023-12-31,total_debt,25225300000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:DebtLongtermAndShorttermCombinedAmount"
  2025,2023-12-31,stockholders_equity,10771900000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:StockholdersEquity"
  2025,2023-12-31,operating_cash_flow,4240000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:NetCashProvidedByUsedInOperatingActivities"
  2025,2023-12-31,depreciation_and_amortization,1527000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:DepreciationDepletionAndAmortization"
  2025,2023-12-31,stock_based_compensation,629000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:ShareBasedCompensation"
  2025,2023-12-31,capex,3448000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment"
  2025,2023-12-31,free_cash_flow,792000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"derived:operating_cash_flow-minus-capex"
  2025,2023-12-31,dividends_paid,4069000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:PaymentsOfDividends"
  2025,2023-12-31,share_repurchases,750000000.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:PaymentsForRepurchaseOfCommonStock"
  2025,2023-12-31,impairments,0.0,USD,USD,2026-02-12,10-K,0000059478-26-000013,"us-gaap:GoodwillImpairmentLoss"
  2024,2022-12-31,revenue,28541400000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:Revenues"
  2024,2022-12-31,cost_of_revenue,6629800000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:CostOfGoodsAndServicesSold"
  2024,2022-12-31,selling_general_and_administrative,6440400000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:SellingGeneralAndAdministrativeExpense"
  2024,2022-12-31,research_and_development,7190800000.0,USD,USD,2023-02-22,10-K,0000059478-23-000082,"us-gaap:ResearchAndDevelopmentExpense"
  2024,2022-12-31,interest_expense,331600000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:InterestExpense"
  2024,2022-12-31,pretax_income,6806400000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
  2024,2022-12-31,income_tax_expense,561600000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:IncomeTaxExpenseBenefit"
  2024,2022-12-31,net_income,6244800000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:NetIncomeLoss"
  2024,2022-12-31,cash_and_equivalents,2067000000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:CashAndCashEquivalentsAtCarryingValue"
  2024,2022-12-31,current_assets,18034500000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:AssetsCurrent"
  2024,2022-12-31,total_assets,49489800000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:Assets"
  2024,2022-12-31,current_liabilities,17138200000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:LiabilitiesCurrent"
  2024,2022-12-31,total_debt,16238600000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:DebtLongtermAndShorttermCombinedAmount"
  2024,2022-12-31,stockholders_equity,10649800000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:StockholdersEquity"
  2024,2022-12-31,operating_cash_flow,7585700000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:NetCashProvidedByUsedInOperatingActivities"
  2024,2022-12-31,depreciation_and_amortization,1522500000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:DepreciationDepletionAndAmortization"
  2024,2022-12-31,stock_based_compensation,371100000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:ShareBasedCompensation"
  2024,2022-12-31,capex,1854300000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment"
  2024,2022-12-31,free_cash_flow,5731400000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"derived:operating_cash_flow-minus-capex"
  2024,2022-12-31,dividends_paid,3535800000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:PaymentsOfDividends"
  2024,2022-12-31,share_repurchases,1500000000.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:PaymentsForRepurchaseOfCommonStock"
  2024,2022-12-31,impairments,0.0,USD,USD,2025-02-19,10-K,0000059478-25-000067,"us-gaap:GoodwillImpairmentLoss"
  2023,2021-12-31,revenue,28318400000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:Revenues"
  2023,2021-12-31,cost_of_revenue,7312800000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:CostOfGoodsAndServicesSold"
  2023,2021-12-31,selling_general_and_administrative,6431600000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:SellingGeneralAndAdministrativeExpense"
  2023,2021-12-31,research_and_development,6930700000.0,USD,USD,2023-02-22,10-K,0000059478-23-000082,"us-gaap:ResearchAndDevelopmentExpense"
  2023,2021-12-31,interest_expense,339800000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:InterestExpense"
  2023,2021-12-31,pretax_income,6155500000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"
  2023,2021-12-31,income_tax_expense,573800000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:IncomeTaxExpenseBenefit"
  2023,2021-12-31,net_income,5581700000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:NetIncomeLoss"
  2023,2021-12-31,cash_and_equivalents,3818500000.0,USD,USD,2023-02-22,10-K,0000059478-23-000082,"us-gaap:CashAndCashEquivalentsAtCarryingValue"
  2023,2021-12-31,current_assets,18452400000.0,USD,USD,2023-02-22,10-K,0000059478-23-000082,"us-gaap:AssetsCurrent"
  2023,2021-12-31,total_assets,48806000000.0,USD,USD,2023-02-22,10-K,0000059478-23-000082,"us-gaap:Assets"
  2023,2021-12-31,current_liabilities,15052700000.0,USD,USD,2023-02-22,10-K,0000059478-23-000082,"us-gaap:LiabilitiesCurrent"
  2023,2021-12-31,total_debt,16884700000.0,USD,USD,2023-02-22,10-K,0000059478-23-000082,"us-gaap:DebtLongtermAndShorttermCombinedAmount"
  2023,2021-12-31,stockholders_equity,8979200000.0,USD,USD,2023-02-22,10-K,0000059478-23-000082,"us-gaap:StockholdersEquity"
  2023,2021-12-31,operating_cash_flow,7365900000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:NetCashProvidedByUsedInOperatingActivities"
  2023,2021-12-31,depreciation_and_amortization,1547600000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:DepreciationDepletionAndAmortization"
  2023,2021-12-31,stock_based_compensation,342800000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:ShareBasedCompensation"
  2023,2021-12-31,capex,1309800000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment"
  2023,2021-12-31,free_cash_flow,6056100000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"derived:operating_cash_flow-minus-capex"
  2023,2021-12-31,dividends_paid,3086800000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:PaymentsOfDividends"
  2023,2021-12-31,share_repurchases,1250000000.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:PaymentsForRepurchaseOfCommonStock"
  2023,2021-12-31,impairments,0.0,USD,USD,2024-02-21,10-K,0000059478-24-000065,"us-gaap:GoodwillImpairmentLoss"

articles[0]{date,title,url,series,section,human_url}: